GB1439742A - Live influenza type b virus vaccines and preparation thereof - Google Patents

Live influenza type b virus vaccines and preparation thereof

Info

Publication number
GB1439742A
GB1439742A GB453575A GB453575A GB1439742A GB 1439742 A GB1439742 A GB 1439742A GB 453575 A GB453575 A GB 453575A GB 453575 A GB453575 A GB 453575A GB 1439742 A GB1439742 A GB 1439742A
Authority
GB
United Kingdom
Prior art keywords
strain
attenuated
recombinant
influenza type
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB453575A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recherche et Industrie Therapeutiques
Original Assignee
Recherche et Industrie Therapeutiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recherche et Industrie Therapeutiques filed Critical Recherche et Industrie Therapeutiques
Publication of GB1439742A publication Critical patent/GB1439742A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB453575A 1974-02-04 1975-02-03 Live influenza type b virus vaccines and preparation thereof Expired GB1439742A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43917674A 1974-02-04 1974-02-04

Publications (1)

Publication Number Publication Date
GB1439742A true GB1439742A (en) 1976-06-16

Family

ID=23743623

Family Applications (1)

Application Number Title Priority Date Filing Date
GB453575A Expired GB1439742A (en) 1974-02-04 1975-02-03 Live influenza type b virus vaccines and preparation thereof

Country Status (21)

Country Link
JP (1) JPS50107122A (enExample)
AT (1) AT338416B (enExample)
BE (1) BE824970A (enExample)
CA (1) CA1047922A (enExample)
CH (1) CH596316A5 (enExample)
CS (1) CS202545B2 (enExample)
DD (1) DD116474A5 (enExample)
DE (1) DE2504373A1 (enExample)
DK (1) DK141926B (enExample)
ES (1) ES434384A1 (enExample)
FI (1) FI750260A7 (enExample)
FR (1) FR2259616B1 (enExample)
GB (1) GB1439742A (enExample)
HU (1) HU170522B (enExample)
IE (1) IE42043B1 (enExample)
IL (1) IL46446A (enExample)
LU (1) LU71784A1 (enExample)
NL (1) NL7501028A (enExample)
NO (1) NO750295L (enExample)
SE (1) SE424503B (enExample)
ZA (1) ZA75248B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2588918A (en) * 1947-11-07 1952-03-11 William T Graham Mechanism for raising and lowering plow frames relative to the ground wheels
JPS6042209B2 (ja) * 1974-05-31 1985-09-20 北里研究所(社団法人) インフルエンザウイルスの新鮮分離株を発育鶏卵へ短期間で順化させる方法

Also Published As

Publication number Publication date
DK141926C (enExample) 1981-01-19
FR2259616A1 (enExample) 1975-08-29
DK9775A (enExample) 1975-09-29
SE7500549L (enExample) 1975-08-05
NL7501028A (nl) 1975-08-06
DK141926B (da) 1980-07-21
IE42043B1 (en) 1980-05-21
ES434384A1 (es) 1976-12-01
CS202545B2 (en) 1981-01-30
DD116474A5 (enExample) 1975-11-20
BE824970A (fr) 1975-07-30
FR2259616B1 (enExample) 1980-01-04
AT338416B (de) 1977-08-25
SE424503B (sv) 1982-07-26
DE2504373A1 (de) 1975-08-07
FI750260A7 (enExample) 1975-08-05
AU7734675A (en) 1976-07-15
CH596316A5 (enExample) 1978-03-15
ZA75248B (en) 1976-01-28
CA1047922A (en) 1979-02-06
JPS50107122A (enExample) 1975-08-23
NO750295L (enExample) 1975-09-01
LU71784A1 (enExample) 1975-06-24
IE42043L (en) 1975-08-04
HU170522B (enExample) 1977-06-28
ATA76675A (de) 1976-12-15
IL46446A0 (en) 1975-04-25
IL46446A (en) 1978-01-31

Similar Documents

Publication Publication Date Title
FI905184A0 (fi) Kimeriska glykoproteiner som innehaoller immunogeniska delar av human parainfluensa-virus typ 3.
ES2035818T3 (es) Mutantes de delecion de la timidin-kinasa del virus del herpes bovino-1, vacunas contra la rinotraqueitis bovina infecciosa que los contienen y metodos para su produccion y uso.
IL130075A0 (en) A vaccine for eliciting an immune response to an antigen in an animal
IE780811L (en) Vaccine against newcastle disease
DE2610540C2 (de) Verwendung eines OEP als Wirkstoff enthaltenden injizierbaren Impfstoffes zur Vorbeugung gegen die durch Pseudomonas aeruginosa hervorgerufene Pneumonitis der Nerze
CA1336262C (en) Mycoplasma vaccine
EP1323428A3 (en) Avirulent Salmonella typhi microbes and uses thereof
JPS5527178A (en) Live influenza virus vaccine
GB1430711A (en) Live bovine and method ofvaccination using them
GB1256456A (en) Ethylethyleneimine as inactivating agent in antigen-containing pharmaceutical preparations
GB1292803A (en) Improvements relating to the production of antigens
Le Cam et al. Adjuvants for influenza vaccine
IE42043L (en) Influenza type b virus vaccines.
ES2079851T3 (es) Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas.
US3961046A (en) Mumps vaccine and preparation thereof
WO1999053950A3 (en) Live vaccines and methods of treatment therewith
IL41902A (en) Immunogenic substance,its production,vaccine preparations containing it and their preparation
GB1461188A (en) Live influenza virus vaccines and preparation thereof
GB1316168A (en) Poultry vaccine
CA2224309A1 (en) Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
GB1256457A (en) Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation
GB1290141A (enExample)
EP0351908B1 (en) Live newcastle disease virus vacccines
EP0338437A3 (de) Synthetische Vakzine gegen die Maul- und Klauenseuche und Verfahren zu deren Herstellung
GB1152607A (en) Antigenic Compositions

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee